Search
Journey Medical Corp
DERMAdd to Watchlist
6.535USD
-0.115-1.73%
Market hours （ET）Quotes delayed by 15 min
177.39MMarket Cap
LossP/E TTM
More Details of Journey Medical Corp Company
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
Journey Medical Corp Profile
Ticker SymbolDERM
Company nameJourney Medical Corp
IPO dateNov 12, 2021
CEOMaraoui (Claude)
Number of employees41
Security typeOrdinary Share
Fiscal year-endNov 12
Address9237 E Via De Ventura Blvd., Suite 105
CitySCOTTSDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code85258
Phone14804346670
Websitehttps://journeymedicalcorp.com/
Ticker SymbolDERM
IPO dateNov 12, 2021
CEOMaraoui (Claude)
Company Executives of Journey Medical Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel, Corporate Secretary
Chief Operating Officer, General Counsel, Corporate Secretary
470.73K
+32.73%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
470.73K
+32.73%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Mr. Joseph Benesch, CPA
Mr. Joseph Benesch, CPA
Chief Financial Officer, Corporate Controller
Chief Financial Officer, Corporate Controller
187.57K
+46.27%
Mr. Joseph Benesch, CPA
Mr. Joseph Benesch, CPA
Chief Financial Officer, Corporate Controller
Chief Financial Officer, Corporate Controller
187.57K
+46.27%
Mr. Neil Herskowitz
Mr. Neil Herskowitz
Independent Director
Independent Director
141.44K
+35.35%
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Independent Director
Independent Director
141.44K
+35.35%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel, Corporate Secretary
Chief Operating Officer, General Counsel, Corporate Secretary
470.73K
+32.73%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
470.73K
+32.73%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
FAQs
Who are the top five shareholders of Journey Medical Corp?
The top five shareholders of Journey Medical Corp are: Mr. Claude Maraoui
How many institutions hold shares of Journey Medical Corp (DERM)?
As of 2026Q1, 137 institutions hold shares of Journey Medical Corp, with a combined market value of approximately 12.08M, accounting for 56.62% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 2740272.00.
What is the biggest source of revenue for Journey Medical Corp?
In 2026Q1, the Qbrexa business generated the highest revenue for Journey Medical Corp, amounting to 25.01M and accounting for 40.85% of total revenue.